Lawyers in our Mass Torts Section continue to receive reports from kidney disease patients who have suffered debilitating injuries caused by nephrogenic systemic fibrosis (NSF) due to receiving gadolinium-based contrast agents during MRI scans. Hundreds of lawsuits have been filed across the United States by individuals with impaired kidney function who had received gadolinium-based contrast agents and developed NSF.
The first NSF trial was scheduled for January 24th before Judge Polster in the U.S. District Court, Northern District of Ohio. We had not gotten a report on that case at press time. Hopefully, the trial got underway. The Plaintiffs in the case, Loralei and Donald Knase, filed a lawsuit against GE Healthcare after Loralei Knase developed NSF following MRI scans during which she received Omniscan. Mrs. Knase suffers from fibrosis in her hands, feet, arms, and legs. Settlements were reportedly reached in the other cases that were previously set for trial. The Plaintiffs’ Steering Committee (PSC) recently filed a request for an order setting additional cases for trial in the Gadolinium MDL.
In 2007, the FDA asked manufacturers of gadolinium-based contrast agents to include a “black box” warning on their products’ labeling stating that those with kidney problems who receive gadolinium-based contrast agents are at risk for developing NSF. The FDA recently mandated additional changes to labeling to safeguard those with kidney disease from receiving gadolinium-based contrast agents. NSF causes hardening of the skin and fibrosis of organs, which may lead to death. Unfortunately, NSF has no known treatment or cure.
Our firm is evaluating cases involving NSF resulting from receiving gadolinium-based contrast agents. If you have a need for more information, contact Roger Smith, a lawyer in our Mass Torts Section, at 800-898-2034 or by email at Roger.Smith@beasleyallen.com.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.